Ionis Pharmaceuticals(IONS) - 2025 Q4 - Earnings Call Presentation

Brett Monia, Ph.D. Chief Executive Officer Holly Kordasiewicz, Ph.D. Chief Development Officer YE:2025 Business Update and Financial Results February 25, 2026 Nasdaq: IONS 1 On Today's Earnings Call Beth Hougen Chief Financial Officer Eugene Schneider, M.D. Chief Clinical Development Officer 2 Eric Swayze, Ph.D. Executive Vice President, Research Forward-Looking Statements This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial pote ...